Surgalign Holdings Inc
XBER:RT2
Surgalign Holdings Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Surgalign Holdings Inc hold over its rivals?
What risks and challenges
does Surgalign Holdings Inc face in the near future?
Provide an overview of the primary business activities
of Surgalign Holdings Inc.
Show me price targets
for Surgalign Holdings Inc made by professional analysts.
Provide an overview of the primary business activities
of Surgalign Holdings Inc.
What unique competitive advantages
does Surgalign Holdings Inc hold over its rivals?
What risks and challenges
does Surgalign Holdings Inc face in the near future?
Summarize the latest earnings call
of Surgalign Holdings Inc.
Show all valuation multiples
for Surgalign Holdings Inc.
Provide P/S
for Surgalign Holdings Inc.
Provide P/E
for Surgalign Holdings Inc.
Provide P/OCF
for Surgalign Holdings Inc.
Provide P/FCFE
for Surgalign Holdings Inc.
Provide P/B
for Surgalign Holdings Inc.
Provide EV/S
for Surgalign Holdings Inc.
Provide EV/GP
for Surgalign Holdings Inc.
Provide EV/EBITDA
for Surgalign Holdings Inc.
Provide EV/EBIT
for Surgalign Holdings Inc.
Provide EV/OCF
for Surgalign Holdings Inc.
Provide EV/FCFF
for Surgalign Holdings Inc.
Provide EV/IC
for Surgalign Holdings Inc.
Show me price targets
for Surgalign Holdings Inc made by professional analysts.
What are the Revenue projections
for Surgalign Holdings Inc?
How accurate were the past Revenue estimates
for Surgalign Holdings Inc?
What are the Net Income projections
for Surgalign Holdings Inc?
How accurate were the past Net Income estimates
for Surgalign Holdings Inc?
What are the EPS projections
for Surgalign Holdings Inc?
How accurate were the past EPS estimates
for Surgalign Holdings Inc?
What are the EBIT projections
for Surgalign Holdings Inc?
How accurate were the past EBIT estimates
for Surgalign Holdings Inc?
Compare the revenue forecasts
for Surgalign Holdings Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Surgalign Holdings Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Surgalign Holdings Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Surgalign Holdings Inc compared to its peers.
Compare the P/E ratios
of Surgalign Holdings Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Surgalign Holdings Inc with its peers.
Analyze the financial leverage
of Surgalign Holdings Inc compared to its main competitors.
Show all profitability ratios
for Surgalign Holdings Inc.
Provide ROE
for Surgalign Holdings Inc.
Provide ROA
for Surgalign Holdings Inc.
Provide ROIC
for Surgalign Holdings Inc.
Provide ROCE
for Surgalign Holdings Inc.
Provide Gross Margin
for Surgalign Holdings Inc.
Provide Operating Margin
for Surgalign Holdings Inc.
Provide Net Margin
for Surgalign Holdings Inc.
Provide FCF Margin
for Surgalign Holdings Inc.
Show all solvency ratios
for Surgalign Holdings Inc.
Provide D/E Ratio
for Surgalign Holdings Inc.
Provide D/A Ratio
for Surgalign Holdings Inc.
Provide Interest Coverage Ratio
for Surgalign Holdings Inc.
Provide Altman Z-Score Ratio
for Surgalign Holdings Inc.
Provide Quick Ratio
for Surgalign Holdings Inc.
Provide Current Ratio
for Surgalign Holdings Inc.
Provide Cash Ratio
for Surgalign Holdings Inc.
What is the historical Revenue growth
over the last 5 years for Surgalign Holdings Inc?
What is the historical Net Income growth
over the last 5 years for Surgalign Holdings Inc?
What is the current Free Cash Flow
of Surgalign Holdings Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Surgalign Holdings Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
S
|
Surgalign Holdings Inc
XBER:RT2
|
20.1m EUR | -0.2 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
35.3B CHF | 18.3 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.4T JPY | 19.5 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
138.4B DKK | 17.6 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
14.5B USD | 17 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.8B CHF | 31.6 |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP | 208.2 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.6B CNY | 26.3 |
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
5B USD | 17.2 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD | 9.1 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5B USD | 18.9 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
S
|
Surgalign Holdings Inc
XBER:RT2
|
Average EV/EBITDA:
38.4
|
N/A | N/A | |
CH |
![]() |
Alcon AG
SIX:ALC
|
18.3
|
10%
|
1.8 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
19.5
|
9%
|
2.2 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
17.6
|
9%
|
2 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
17
|
15%
|
1.1 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
31.6
|
N/A | N/A |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
208.2
|
11%
|
18.9 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
26.3
|
18%
|
1.5 |
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
17.2
|
19%
|
0.9 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
9.1
|
21%
|
0.4 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
18.9
|
12%
|
1.6 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.